Mechanically Activated Microcapsules for “On‐Demand” Drug Delivery in Dynamically Loaded Musculoskeletal Tissues
- 17 February 2019
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 29 (15)
Abstract
Delivery of biofactors in a precise and controlled fashion remains a clinical challenge. Stimuli‐responsive delivery systems can facilitate “on‐demand” release of therapeutics in response to a variety of physiologic triggering mechanisms (e.g., pH, temperature). However, few systems to date have taken advantage of mechanical inputs from the microenvironment to initiate drug release. Here, mechanically activated microcapsules (MAMCs) are designed to deliver therapeutics in response to the mechanically loaded environment of regenerating musculoskeletal tissues, with the ultimate goal of furthering tissue repair. To establish a suite of microcapsules with different thresholds for mechanoactivation, MAMC physical dimensions and composition are first manipulated, and their mechano‐response under both direct 2D compression and in 3D matrices mimicking the extracellular matrix properties and dynamic loading environment of regenerating tissue, is evaluated. To demonstrate the feasibility of this delivery system, an engineered cartilage model is used to test the efficacy of mechanically instigated release of transforming growth factor‐β3 on the chondrogenesis of mesenchymal stem cells. These data establish a novel platform by which to tune the release of therapeutics and/or regenerative factors based on the physiologic mechanical loading environment and will find widespread application in the repair and regeneration of musculoskeletal tissues.Keywords
Funding Information
- National Institutes of Health (T32 AR007132)
- U.S. Department of Veterans Affairs (R01 EB008722, I01 RX001213)
- National Science Foundation (CBET‐1604536)
This publication has 70 references indexed in Scilit:
- Biodegradable Core–Shell Carriers for Simultaneous Encapsulation of Synergistic ActivesJournal of the American Chemical Society, 2013
- Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood VesselsScience, 2012
- IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitroArthritis Research & Therapy, 2012
- Controlling the Stability and Size of Double-Emulsion-Templated Poly(lactic-co-glycolic) Acid MicrocapsulesLangmuir, 2012
- The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructsBiomaterials, 2010
- TGF‐β3 immobilized PLGA‐gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regenerationJournal of Biomedical Materials Research Part A, 2010
- An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineeringBiomaterials, 2010
- Chondrogenic differentiation of human mesenchymal stem cell aggregates via controlled release of TGF‐β1 from incorporated polymer microspheresJournal of Biomedical Materials Research Part A, 2009
- An in vivo study of a growth-factor enhanced, cell free, two-layered collagen–tricalcium phosphate in deep osteochondral defectsBiomaterials, 2006
- Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation methodBiomaterials, 2001